METALLOTHIONEIN: An Intracellular Protein to Protect Against Cadmium Toxicity
Tóm tắt
▪ Abstract Metallothioneins (MT) are low-molecular-weight, cysteine-rich, metal-binding proteins. MT genes are readily induced by various physiologic and toxicologic stimuli. Because the cysteines in MT are absolutely conserved across species, it was suspected that the cysteines are necessary for function and MT is essential for life. In attempts to determine the function(s) of MT, studies have been performed using four different experimental paradigms: (a) animals injected with chemicals known to induce MT; (b) cells adapted to survive and grow in high concentrations of MT-inducing toxicants; (c) cells transfected with the MT gene; and (d) MT-transgenic and MT-null mice. Most often, results from studies using the first three approaches have indicated multiple functions of MT in cell biology: MT (a) is a “storehouse” for zinc, (b) is a free-radical scavenger, and (c) protects against cadmium (Cd) toxicity. However, studies using MT-transgenic and null mice have not strongly supported the first two proposed functions but strongly support its function in protecting against Cd toxicity. Repeated administration of Cd to MT-null mice results in nephrotoxicity at one tenth the dose that produces nephrotoxicity in control mice. Human studies indicate that 7% of the general population have renal dysfunction from Cd exposure. Therefore, if humans did not have MT, “normal” Cd exposure would be nephrotoxic to humans. Thus, it appears that during evolution, the ability of MT to protect against Cd toxicity might have taken a more pivotal role in the maintenance of life processes, as compared with its other proposed functions (i.e. storehouse for zinc and free radical scavenger).
Từ khóa
Tài liệu tham khảo
Kägi JHR. 1993. Evolution, structure and chemical activity of class I metallothioneins: An overview. InMetallothionein III: Biological Roles and Medical Implications, ed. KT Suzuki, N Imura, M Kimura, pp. 29–56. Berlin: Birkhauser
Hunziker PE, Kagi JHR. 1985. Metal proteins with non-redox roles. InMetalloproteins, ed. PM Harrison, 2:149–81. Berlin: Chemie
Skroch P, 1993, Prog. Clin. Biol. Res., 380, 113
Palmiter RD, 1987, Experientia, 52, 63
Andrews GK, 1990, Prog. Food Nutr. Sci., 14, 193
Heuchel R, 1994, EMBO J., 12, 1355
McKim JM, 1993, Toxicologist, 13, 572
Brady FO, 1982, Dev. Toxicol. Environ. Sci., 9, 77
Kelly EJ, 1996, J. Nutr., 126, 1782
Suzuki KT, 1995, Res. Commun. Mol. Pathol. Pharmacol., 89, 221
Nartey NO, 1987, Lab. Invest., 57, 397
Durnam DM, 1987, Experientia, 52, 457
Deng DX, 1998, Lab. Invest., 78, 175
Klaassen CD, 1978, Am. J. Physiol., 234, E47
Liu Y, 1993, J. Pharmacol. Exp. Ther., 266, 400
Liu J, 1996, J. Pharmacol. Exp. Ther., 276, 1216
Nordberg GF, 1975, Arch. Pathol., 99, 192
Liu J, 1998, Toxicol. Sci.
Habeebu SS, Liu J, Liu YP, Klaassen CD. 1997. Metallothionein null mice are vulnerable to chronic CdCl2-induced hepatotoxicity. 4th Int. Metallothionein Meet., Kansas City, Abstr. 147
Bhattacharrya MH, 1998, The role of metallothionein in cadmium-induced bone resorption.
Habeebu SSM, 1998, Toxicol. Sci., 42, 1606
Liu J, 1998, Toxicol. Sci., 42, 1605
Klaassen CD, 1996, Fundam. Appl. Toxicol., 30, 721
Evans RM, 1983, Mol. Pharmacol., 24, 77
Satoh M, 1997, J. Pharmacol. Exp. Ther., 283, 1529
Min KS, 1998, Protective effect of metallothionein on DNA damage induced by hydrogen peroxide and ferric ion-nitrilotriacetic acid.
Pitt BR, Am. J. Physiol., 273, L856
Kondo Y, 1995, Cancer Res., 55, 2021
DiSilvestro RA, 1996, Res. Commun. Mol. Pathol. Pharmacol., 93, 163
Kang YJ, 1998, Cardiac protection by metallothionein against ischemia-reperfusion injury and its possible relation to ischemic preconditioning.
Wang GW, 1999, J. Pharmacol. Exp. Ther.
Conrad CC, Grabowski DT, Walter CA, Richardson A. 1997. Metallothionein does not protect mice in vivo from oxidative damage. 4th Int. Metallothionein Meet., Kansas City, Abstr. 161
Satoh M, 1998, Susceptibility to metals and radical-inducing chemicals of metallothionein-null mice.
Woo ES, 1997, Cancer Res., 57, 4236
Kasahara K, 1991, Cancer Res., 51, 3237
Naganuma A, 1997, Cancer Res., 47, 983
Morton KA, 1993, J. Pharmacol. Exp. Ther., 267, 697
Koropatnick J, 1993, Mol. Pharmacol., 44, 44
Liu YP, 1998, Toxicol. Lett., 95, 75
Liu Y, 1993, J. Pharmacol. Exp. Ther., 266, 400
Liu J, 1999, J. Pharmacol. Exp. Ther.
Minami T, 1997, MT does not protect endocrine damage induced by alloxan in pancreas of mice.
Rojas P, 1996, Neurotoxicology, 17, 323
Li WH, 1991, Fundamentals of Molecular Evolution.
Ridley M, 1996, Evolution.
Hamer D, Culotta V, Furst P, Hackett R, Hsu T, Hu S, et al. 1991. Function and regulation of yeast Cu-metallothionein. InMetallothionein in Biology and Medicine, ed. CD Klaassen, KT Suzuki, pp. 75–86. Boca Raton, FL: CRC. 414 pp.
Klaassen CD. 1996. Heavy metals and heavy-metal antagonists. InGoodman & Gilman's The Pharmacological Basis of Therapeutics, ed. JG Hardman, LE Limbird, PB Molinoff, RW Ruddon, AG Gilman, pp. 1649–72. New York: McGraw-Hill
Klaassen CD, 1998, Metallothionein IV.